Regarding the mechanisms involved in driving NK dysregulation in solid pediatric cancers, we showed that these patients did not have raised plasma levels of soluble ULBP2 or soluble MICA, both of which inhibit NK cell function in some adult cancer patients.42 The gene discussed is ULBP2; the disease is cancer.